Skip to contentT
Tenon Medical, Inc.
T
TNONWTenon Medical, Inc. Q2 2024 · 10-Q
Revenue$901.00K$901.00K+21.3% vs Q2 2023 Net Income-$3.83M-$3.83MN/M vs Q2 2023 EPS Diluted-$8.16-$8.16N/M vs Q2 2023 Gross Profit$470,000+142.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenon Medical, Inc. · CIK 1560293 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,420,000N/M Free Cash Flowderived-$2,420,000N/M Margins · derivedGross margin52.2%+26.1 pt vs Q2 2023
Operating margin-429.7%+152.0 pt vs Q2 2023
Net margin-424.6%+152.1 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 13, 2024 · 44 d after period end